Latest Insulin Stories
SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin. "An ambulatory device...
SOUTH HACKENSACK, N.J., Jan. 8, 2013 /PRNewswire/ -- Naturex, the global leader in natural specialty ingredients, is the creator of Svetol®, the most studied and proven green coffee bean extract for weight loss. By regulating sugar and fat use as a source of energy, this revolutionary ingredient is the only plant extract of decaffeinated green coffee that simultaneously spurs weight loss and improves your body's form (www.svetol.com). Svetol® is a unique green coffee bean...
INDIANAPOLIS and ROLLING MEADOWS, Ill., Jan. 8, 2013 /PRNewswire/ -- For a second year in a row, Lilly Diabetes will donate $100,000 to the Diabetes Scholars Foundation (Foundation) scholarship fund. The contribution will support the Foundation's mission to empower young people with type 1 diabetes to live their lives to the fullest. The Foundation will use the donation to fund the Lilly Diabetes Tomorrow's Leaders Scholarships for students with type 1 diabetes as well as conference...
University of Florida researchers and colleagues have identified a protein that, when absent, helps the body burn fat and prevents insulin resistance and obesity. The findings from the National Institutes of Health-funded study were published online ahead of print Sunday, Jan. 6, in the journal Nature Medicine. The discovery could aid development of drugs that not only prevent obesity, but also spur weight loss in people who are already overweight, said Stephen Hsu, M.D., Ph.D., one of...
JERUSALEM, January 7, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a Phase 2 clinical trial of its orally ingested insulin candidate, ORMD-0801. The IND application was filed with the FDA on December 31, 2012. The trial is to include 147 type 2 diabetic...
INGELHEIM, Germany, Jan. 7, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT-2) inhibitor being studied for treatment of patients with type 2 diabetes (T2D). In all four studies, the primary efficacy endpoint, defined as significant change in HbA1c from baseline compared to placebo, was met with...
INDIANAPOLIS and INGELHEIM, Germany, Jan. 7, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim International GmbH announced today they will adjust the scope of their diabetes alliance with respect to LY2605541*, Lilly's investigational novel basal insulin analog, with Lilly reassuming sole worldwide development and commercialization rights to LY2605541. Lilly and Boehringer Ingelheim formed their diabetes alliance in January 2011, centering on four...
ORLANDO, Fla., Jan. 7, 2013 /PRNewswire/ -- Dr. Edwin Lee of The Institute for Hormonal Balance, in his book, Your Best Investment: Secrets to a Healthy Body and Mind, provides a new approach to healthy nutrition that is based on obesity's relationship with high insulin levels. With high insulin levels being the "common thread" between obesity, high blood pressure, heart disease, stroke, cancer, diabetes and many other conditions, Dr. Lee's approach to nutrition provides total health...
redOrbit Staff & Wire Reports - Your Universe Online Changes in a person's cellular metabolism, not genetic predisposition, may be the primary factor that causes a person to contract Type 2 diabetes, researchers from the University of California - Santa Barbara (UCSB) have discovered. Building upon previous research at the university, which uncovered the identity of the molecular building blocks required to construct the four types of macromolecules found in all cells, the UCSB team...
Researchers at UNIGE analyze the impact of 3 unexpected sex determination factors So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and...
Latest Insulin Reference Libraries
The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...
